Quanterix Corporation Revenue
Quanterix Corporation (QTRX) reported Revenue of $32.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-10
- Quanterix Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $32.91M, a 34.44% increase year-over-year.
- Quanterix Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $36.41M, a 20.05% increase year-over-year.
- Quanterix Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $43.85M, a 24.73% increase year-over-year.
- Quanterix Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $40.23M, a 12.34% increase year-over-year.
- Quanterix Corporation revenue from contract with customer, excluding assessed tax for fiscal 2025 was $138.90M, a 1.07% increase from fiscal 2024.
- Quanterix Corporation revenue from contract with customer, excluding assessed tax for fiscal 2024 was $137.42M, a 12.30% increase from fiscal 2023.
- Quanterix Corporation revenue from contract with customer, excluding assessed tax for fiscal 2023 was $122.37M, a 15.96% increase from fiscal 2022.
- Quanterix Corporation revenue from contract with customer, excluding assessed tax for fiscal 2022 was $105.52M, a 4.55% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32.91M 10-Q · filed 2026-08-10 | $69.32M 10-Q · filed 2026-08-10 | $113.18M derived: sum of 3 quarters · filed 2026-08-10 | $153.41M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $36.41M 10-Q · filed 2026-05-06 | $80.27M derived: sum of 2 quarters · filed 2026-05-06 | $120.50M derived: sum of 3 quarters · filed 2026-05-06 | $144.98M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $43.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $84.09M derived: sum of 2 quarters · filed 2026-03-02 | $108.56M derived: sum of 3 quarters · filed 2026-08-10 | $138.90M 10-K · filed 2026-03-02 | ||
| 2025-09-30 | $40.23M 10-Q · filed 2025-11-10 | $64.71M derived: sum of 2 quarters · filed 2026-08-10 | $95.04M 10-Q · filed 2025-11-10 | $130.20M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $24.48M 10-Q · filed 2026-08-10 | $54.81M 10-Q · filed 2026-08-10 | $89.97M derived: sum of 3 quarters · filed 2026-08-10 | $125.78M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $30.33M 10-Q · filed 2026-05-06 | $65.49M derived: sum of 2 quarters · filed 2026-05-06 | $101.31M derived: sum of 3 quarters · filed 2026-05-06 | $135.69M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $35.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $70.97M derived: sum of 2 quarters · filed 2026-03-02 | $105.36M derived: sum of 3 quarters · filed 2026-03-02 | $137.42M 10-K · filed 2026-03-02 | ||
| 2024-09-30 | $35.81M 10-Q · filed 2025-11-10 | $70.19M derived: sum of 2 quarters · filed 2025-11-10 | $102.26M 10-Q · filed 2025-11-10 | $133.81M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $34.38M 10-Q · filed 2025-08-07 | $66.45M 10-Q · filed 2025-08-07 | $98.00M derived: sum of 3 quarters · filed 2025-08-07 | $129.56M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $32.07M 10-Q · filed 2025-05-12 | $63.62M derived: sum of 2 quarters · filed 2025-05-12 | $95.17M derived: sum of 3 quarters · filed 2025-05-12 | $125.98M derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $31.55M 10-K/A · filed 2024-12-26 | $63.11M derived: sum of 2 quarters · filed 2024-12-26 | $93.91M derived: sum of 3 quarters · filed 2024-12-26 | $122.37M 10-K · filed 2026-03-02 | ||
| 2023-09-30 | $31.56M 10-K/A · filed 2024-12-26 | $31.33M 10-Q · filed 2023-11-08 | $62.36M derived: sum of 2 quarters · filed 2024-12-26 | $90.82M 10-K/A · filed 2024-12-26 | $116.64M derived: sum of 4 quarters · filed 2024-12-26 | |
| 2023-06-30 | $30.80M 10-K/A · filed 2024-12-26 | $31.03M 10-Q · filed 2023-08-08 | $59.26M 10-K/A · filed 2024-12-26 | $59.48M 10-Q · filed 2023-08-08 | $85.08M derived: sum of 3 quarters · filed 2024-12-26 | $111.73M derived: sum of 4 quarters · filed 2024-12-26 |
| 2023-03-31 | $28.46M 10-K/A · filed 2024-12-26 | $54.28M derived: sum of 2 quarters · filed 2024-12-26 | $80.93M derived: sum of 3 quarters · filed 2024-12-26 | $104.43M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-12-31 | $25.82M 10-K/A · filed 2024-12-26 | $52.47M derived: sum of 2 quarters · filed 2024-12-26 | $75.97M derived: sum of 3 quarters · filed 2024-12-26 | $105.52M 10-K · filed 2025-03-17 | ||
| 2022-09-30 | $26.65M 10-K/A · filed 2024-12-26 | $50.15M derived: sum of 2 quarters · filed 2024-12-26 | $79.70M 10-K/A · filed 2024-12-26 | $109.98M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-06-30 | $23.50M 10-K/A · filed 2024-12-26 | $53.05M 10-K/A · filed 2024-12-26 | $83.34M derived: sum of 3 quarters · filed 2024-12-26 | $111.03M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-03-31 | $29.55M 10-K/A · filed 2024-12-26 | $59.84M derived: sum of 2 quarters · filed 2024-12-26 | $87.53M derived: sum of 3 quarters · filed 2024-12-26 | $112.90M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2021-12-31 | $30.29M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | $57.98M derived: sum of 2 quarters · filed 2024-12-26 | $83.35M derived: sum of 3 quarters · filed 2024-12-26 | $110.56M 10-K/A · filed 2024-12-26 | ||
| 2021-09-30 | $27.69M 10-Q · filed 2022-11-09 | $53.06M derived: sum of 2 quarters · filed 2022-11-09 | $80.27M 10-Q · filed 2022-11-09 | $106.40M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $25.37M 10-Q · filed 2022-08-08 | $52.58M 10-Q · filed 2022-08-08 | $78.71M derived: sum of 3 quarters · filed 2022-08-08 | $110.10M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | $27.21M 10-Q · filed 2022-05-10 | $53.34M derived: sum of 2 quarters · filed 2022-05-10 | $84.73M derived: sum of 3 quarters · filed 2022-05-10 | $97.86M derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $26.13M 10-K · filed 2021-03-05 | $57.52M derived: sum of 2 quarters · filed 2021-11-04 | $70.65M derived: sum of 3 quarters · filed 2021-11-04 | $86.38M 10-K · filed 2023-03-06 | ||
| 2020-09-30 | $31.39M 10-Q · filed 2021-11-04 | $44.52M derived: sum of 2 quarters · filed 2021-11-04 | $60.25M 10-Q · filed 2021-11-04 | $76.16M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $13.13M 10-Q · filed 2021-08-05 | $28.86M 10-Q · filed 2021-08-05 | $44.77M derived: sum of 3 quarters · filed 2021-08-05 | $59.72M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $15.73M 10-Q · filed 2021-05-06 | $31.64M derived: sum of 2 quarters · filed 2021-05-06 | $46.59M derived: sum of 3 quarters · filed 2021-05-06 | $60.12M derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $15.92M 10-K · filed 2021-03-05 | $30.86M derived: sum of 2 quarters · filed 2021-03-05 | $44.40M derived: sum of 3 quarters · filed 2021-03-05 | $56.73M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $14.94M 10-K · filed 2021-03-05 | $28.48M derived: sum of 2 quarters · filed 2021-03-05 | $40.82M 10-Q · filed 2020-11-06 | $51.69M derived: sum of 4 quarters · filed 2021-03-05 | ||
| 2019-06-30 | $13.54M 10-K · filed 2021-03-05 | $25.87M 10-Q · filed 2020-08-04 | $36.75M derived: sum of 3 quarters · filed 2021-03-05 | $47.34M derived: sum of 4 quarters · filed 2021-03-05 | ||
| 2019-03-31 | $12.34M 10-K · filed 2021-03-05 | $23.21M derived: sum of 2 quarters · filed 2021-03-05 | $33.80M derived: sum of 3 quarters · filed 2021-03-05 | $42.45M derived: sum of 4 quarters · filed 2021-03-05 | ||
| 2018-12-31 | $10.88M 10-K · filed 2020-03-13 | $21.47M derived: sum of 2 quarters · filed 2020-03-13 | $30.11M derived: sum of 3 quarters · filed 2020-03-13 | $37.63M 10-K · filed 2021-03-05 | ||
| 2018-09-30 | $10.59M 10-K · filed 2020-03-13 | $19.23M derived: sum of 2 quarters · filed 2020-03-13 | $26.75M 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | $8.64M 10-K · filed 2020-03-13 | $16.16M 10-Q · filed 2019-08-06 | ||||
| 2018-03-31 | $7.52M 10-K · filed 2020-03-13 | |||||
| 2017-12-31 | $22.87M 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |